The International Journal of Pharmaceutics publishes innovative papers, reviews, mini-reviews, rapid
communications and notes dealing with physical, chemical, biological, microbiological and engineering studies related to the conception,
design, production, characterisation and evaluation of drug delivery systems in vitro and in vivo. "Drug" is defined ... click here for full Aims & Scope
The International Journal of Pharmaceutics publishes innovative papers, reviews, mini-reviews, rapid
communications and notes dealing with physical, chemical, biological, microbiological and engineering studies related to the conception,
design, production, characterisation and evaluation of drug delivery systems in vitro and in vivo. "Drug" is defined
as any therapeutic or diagnostic entity, including oligonucleotides, gene constructs and radiopharmaceuticals.
Areas of particular
interest include: physical pharmacy; polymer chemistry and physical chemistry as applied to pharmaceutics; excipient function and characterisation;
biopharmaceutics; absorption mechanisms; membrane function and transport; novel routes and modes of delivery; responsive delivery systems,
feedback and control mechanisms including biosensors; applications of cell and molecular biology to drug delivery; prodrug design; bioadhesion
(carrier-ligand interactions); and biotechnology (protein and peptide formulation and delivery).
Editorial Policy
The
over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not
sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although
the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple
authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript
has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried
out. If accepted, the manuscript shall not be published elsewhere in the same form, in either the same or another language, without the
consent of the Editors and Publisher.
Authors must state in a covering letter when submitting papers for publication the novelty
embodied in their work or in the approach taken in their research. Routine bioequivalence studies are unlikely to find favour. No
paper will be published which does not disclose fully the nature of the formulation used or details of materials which are key to the
performance of a product, drug or excipient. Work which is predictable in outcome, for example the inclusion of another drug in a cyclodextrin
to yield enhanced dissolution, will not be published unless it provides new insight into fundamental principles.
Hide Aims & Scope
Editors-in-Chief: Contact the Editor
A.T. Florence
Home | Elsevier Websites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company